- Time of issue:2020-07-09 00:00:00
Kanova has built an innovative product pipeline from advanced research around immune-oncology and autoimmune diseases. The pipeline will help to address the rapidly growing and unmet clinical needs in China and around the world in these disease areas. Kanova is dedicated to translate the basic research results to industrial R&D, promotes the domestic capabilities to develop innovative drugs, and enhances the international competitiveness of Chinese biotech companies.
Scan the QR code to read on your phone